THC insider Form 4: sales at $204.75, $205.62, $206.51

Q: How many Tenet Healthcare (THC) shares were sold and at what prices?

Reported sales were 8,056 shares at a weighted average $204.75 , 5,066 shares at $205.62 , and 200 shares at $206.51 .

Q: What were the price ranges for the weighted-average sales?

The filing states ranges of $204.21–$205.13 for the first block and $205.21–$206.14 for the second block.

Q: What is the insider’s beneficial ownership after the transactions?

The table shows beneficial ownership of common stock at 0 shares following the reported transactions.

Q: Who signed the filing for the reporting person?

It was signed by Chad J. Wiener as Attorney-in-Fact for R. Scott Ramsey on 11/07/2025 .

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Tenet Healthcare (THC): Insider stock sale disclosed. Principal Accounting Officer R. Scott Ramsey reported open-market sales of common stock on 11/06/2025. Transactions included 8,056 shares at a weighted average price of $204.75 (sold across $204.21–$205.13) and 5,066 shares at a weighted average price of $205.62 (sold across $205.21–$206.14), plus 200 shares at $206.51. After these sales, the table shows beneficial ownership of common stock at 0 shares. The filing lists transaction code “S” for sales and notes weighted-average pricing with details available upon request.

Insights

Routine Form 4 insider sale; administrative disclosure.

Tenet Healthcare reported insider sales by its Principal Accounting Officer, labeled with transaction code “S” for open-market sales. The filing provides weighted-average prices and ranges, indicating multiple executions on 11/06/2025.

The disclosure states totals and price bands, with the signer committing to furnish detailed trade-by-trade data upon request. Cash-flow treatment and use of proceeds are not applicable here; this records a personal sale, not an issuance by the company.

Form 4 filings are standard and primarily informational. Actual impact depends on broader context such as ongoing ownership levels and timing, which are outside this excerpt.

Insider Trade Summary

Net Seller: 13,322 shares

Net Sell 3 txns

Insider Ramsey R. Scott

Role Principal Accounting Officer

Sold 13,322 shs ($2.73M)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,056	$204.75	$1.65M
Sale	Common Stock	5,066	$205.62	$1.04M
Sale	Common Stock	200	$206.51	$41K

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (3)

F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $204.21 to $205.13.
F2. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $205.21 to $206.14.
F3. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 11/07/2025 - 08:00 PM

FAQ

What did Tenet Healthcare (THC) disclose in this Form 4?

An insider, Principal Accounting Officer R. Scott Ramsey, reported sales of common stock on 11/06/2025 with transaction code S for open-market sales.

How many Tenet Healthcare (THC) shares were sold and at what prices?

Reported sales were 8,056 shares at a weighted average $204.75, 5,066 shares at $205.62, and 200 shares at $206.51.

What were the price ranges for the weighted-average sales?

The filing states ranges of $204.21–$205.13 for the first block and $205.21–$206.14 for the second block.

What is the insider’s beneficial ownership after the transactions?

The table shows beneficial ownership of common stock at 0 shares following the reported transactions.

Was a Rule 10b5-1 trading plan indicated?

The form includes a checkbox for Rule 10b5-1(c), but the excerpt does not show it as marked.

Who signed the filing for the reporting person?

It was signed by Chad J. Wiener as Attorney-in-Fact for R. Scott Ramsey on 11/07/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ramsey R. Scott

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

75254

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Principal Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/06/2025		S		8,056	D	$204.75⁽¹⁾⁽³⁾	5,266	D
Common Stock	11/06/2025		S		5,066	D	$205.62⁽²⁾⁽³⁾	200	D
Common Stock	11/06/2025		S		200	D	$206.51	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $204.21 to $205.13.

2. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $205.21 to $206.14.

3. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener as Attorney-in-Fact for R. Scott Ramsey	11/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR